Pharsight

Drugs that contain Fosphenytoin Sodium

1. Sesquient patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9750822 LUPIN Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

US7635773 LUPIN Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

US8410077 LUPIN Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

US9200088 LUPIN Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

US9493582 LUPIN Alkylated cyclodextrin compositions and processes for preparing and using the same
Feb, 2033

(9 years from now)

Market Authorisation Date: 05 November, 2020

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

SESQUIENT family patents

Family Patents